Decision path
Use the guide as a safety framework.
Learn the framework first, then check risk, vendor documentation, and personal fit before choosing a compound path.
01
Learn the framework
02
Check risk
03
Take the quiz
04
Compare vendors
Guide next step
Use the guide before choosing a compound.
Take the quiz after this guide so the next page reflects your goal, risk tolerance, and monitoring comfort.
Why this matters
Vendors often name testing methods without explaining what they actually cover.
Users need to know when a method supports a claim and when it is just decoration.
Testing language is one of the easiest places for weak listings to sound more credible than they are.
Key takeaways
Method names should map to a real quality question such as identity, purity, or contamination.
One method rarely answers every question a user should have.
Method transparency is stronger when it appears in a batch-linked COA, not just in product copy.
If the listing is vague about what was tested, assume the quality evidence is weaker than it sounds.
Guide protocol path
Use this framework before turning research into a protocol.
- 1
Baseline
Clarify goal, labs, contraindications, and sport/testing status.
- 2
Choose
Pick one primary compound path before stacking extras.
- 3
Source
Check vendor documentation, COA fit, and route constraints.
- 4
Monitor
Track outcomes, adverse effects, and stop conditions.
- 5
Reassess
Review whether the protocol still fits after the first cycle.
COA visual
How to read a COA before trusting a vendor
Example certificate
Product purity and identity report
Batch ID
Must match the exact product page or vial label.
Purity
Look for a numeric purity result, not only 'lab tested' language.
Method
HPLC is common for purity; MS helps confirm identity.
Date
Recent tests are more useful than stale or reused reports.
Red flags
Missing batch, cropped lab name, or generic PDF should slow the purchase.
Method names need scope
Good vendors do not just say 'lab tested.' They show what was tested, how it was tested, and ideally when. That is what lets a user connect a claim to a specific quality dimension instead of guessing.
How to compare testing language
| Listing language | Confidence impact |
|---|---|
| 'Lab tested' with no document | Weak |
| Method names but no lot-linked COA | Better than nothing, still limited |
| Batch-linked COA with method and date | Stronger |
| Third-party batch-linked report with readable fields | Strongest retail-facing signal |
Frequently asked questions
Because purity is an easy claim to market. The better question is whether the documentation stops there or shows a fuller testing picture.
Not without batch linkage and readable report details. The lab reference should connect to the actual product record.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Use these guides to build confidence first — then compare compounds, review vendor documentation, and take the quiz when you're ready for a plan.